IVF outcomes for women with Polycystic Ovary Syndrome
Official title: IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome Compared With Non Polycystic Ovary Syndrome Women
Run by Egymedicalpedia · NCT05756023 · Data updated 2026-11-12
This study looks at how well IVF and ICSI work for women with Polycystic Ovary Syndrome who are having trouble getting pregnant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 35 Years |
| Sex | Women only |
| Enrollment | 156 (estimated) |
| Sponsor | Egymedicalpedia Industry-sponsored |
| Locations | 1 site (Asyut) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | December 1, 2026 |
| Study ends | December 15, 2026 |
| Registry record updated | October 19, 2023 |
| Trial ID | NCT05756023 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women of reproductive age diagnosed with PCOS who experience oligo-ovulation or anovulation.
✕Probably not a fit
Patients with androgen-secreting tumors, major uterine anomalies, or other significant endocrine disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the outcomes of in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in women diagnosed with Polycystic Ovary Syndrome (PCOS). It focuses on sub-fertile women who may require assisted reproductive techniques due to challenges such as anovulation and hormonal imbalances. The study aims to evaluate the pregnancy rates associated with these reproductive techniques while considering the unique challenges faced by women with PCOS, including potential complications and the impact of obesity on fertility outcomes.
Why it matters
Potential benefit: If successful, this study could improve IVF success rates for women with PCOS, leading to higher pregnancy and live birth rates.
How similar studies have gone: Other studies have explored IVF outcomes in PCOS patients, but this specific approach to modifying standard protocols is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Oligo-ovulation or anovulation. * Clinical and/or biochemical hyper androgenesim. * Polycystic ovaries. Exclusion Criteria: 1. Androgen-secreting tumors (ovarian or adrenal). 2. Adult-onset congenital adrenal hyperplasia. 3. Thyroid diseases. 4. Cushing's syndrome. 5. Diabetes Mellitus. 6. recurrent ICSI failure 7. endocrine, hematologic and autoimmune disorders 8. Non chromosomal and genetic abnormalities 9. Major uterine anomalies, bad surgical history, sever endometriosis, , hydrosalpinx, uterine fibroids 10. Azospermia
Where it's running
-
Assuit University hospitals
Asyut, Egypt Recruiting
Study contacts
- Study coordinator: Islam Mahfouz, MSC
- Email: islam.ibrahim@med.aun.edu.eg
- Phone: 01118434861
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adding quercetin or alpha-lipoic acid to metformin for women with PCOS
This trial will see if adding quercetin or alpha-lipoic acid to metformin improves hormones, blood sugar, cholesterol, and quality of life in women aged 18–40 with PCOS.
-
Comparing letrozole alone versus letrozole with levothyroxine for women with PCOS and subclinical hypothyroidism
This study is testing if adding levothyroxine to letrozole helps women with PCOS and low thyroid function get pregnant more effectively than letrozole alone.
-
Using Semaglutide to Restore Ovulation in Young Women with PCOS
This study is testing if a medication called semaglutide can help young women with PCOS and obesity start ovulating again.
-
Using LC-MS/MS to profile androgens for PCOS diagnosis
This study tests whether LC-MS/MS measurement of androgen profiles can help diagnose PCOS in women compared with healthy controls.
-
Brown adipose tissue responses in PCOS with infrared thermography and inositol
This study tests whether brown fat activity, measured by infrared skin temperature and UCP-1 levels, differs among women with PCOS (normal weight or overweight/obese) and healthy controls, and whether 12 weeks of inositol changes those responses in overweight/obese PCOS participants.
-
Risk tool for blood-clotting problems in adolescents and women with PCOS
This project will try to build a risk model to spot decreased protein C or S and other clotting abnormalities in females aged 14–45 who have PCOS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.